{
    "title": "Sarepta shares slump as muscle disorder therapy fails to meet key trial goal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12693109/Sarepta-shares-slump-muscle-disorder-therapy-fails-meet-key-trial-goal.html",
    "date": "2023-10-31",
    "keywords": [
        "therapy",
        "approval",
        "trial",
        "gene",
        "disorder",
        "treatment",
        "health",
        "effectiveness",
        "study",
        "premarket",
        "trading",
        "tuesday",
        "musclewasting",
        "goal",
        "price",
        "target",
        "stock",
        "uncertainty",
        "growth",
        "market",
        "elevidys",
        "june",
        "regulator",
        "midstage",
        "version",
        "dystrophin",
        "protein",
        "patient",
        "ability",
        "latestage",
        "therapys",
        "dystrophy",
        "motor",
        "function",
        "safety",
        "sarepta",
        "age",
        "year",
        "reporting",
        "mariam",
        "sunny",
        "bengaluru",
        "editing",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}